Dataset Information

The potential individual- and population-level benefits of encouraging drinkers to count their drinks.

ABSTRACT:

Introduction

Cross-sectional studies have established a link between overall engagement in protective behavioral strategies (PBSs) and reduced alcohol consumption. However, there are mixed results on the effectiveness of individual PBSs, with some found to result in increased consumption. A recent study examining the effects of PBS use over time found the 'Count your drinks' strategy to be most reliably associated with reduced alcohol consumption among 16 strategies. Given the apparent superior efficacy of this PBS, this exploratory study aimed to extend these results by (i) determining the extent to which increasing the frequency of PBS enactment is associated with alcohol consumption over time and (ii) predicting potential changes in population-level consumption resulting from higher levels of PBS use.

Method

1250 drinkers aged 18-70 years provided data at two time points relating to their drinking practices. Multiple regression analyses were conducted to model the relationship between changes in frequency of enactment of the 'Count your drinks' PBS and alcohol consumption. Coefficients were used to predict average reductions in alcohol consumption over one year associated with increased frequency of use of this PBS.

Results

Larger increases in the frequency of using the 'Count your drinks' PBS were associated with greater reductions in alcohol consumption. Exploratory extrapolation analyses demonstrated the potential for substantial reductions in overall alcohol consumption.

Conclusion

The results suggest health promotion efforts designed to increase the frequency with which drinkers count their drinks could produce substantial annual decreases in alcohol consumption at both individual and population levels.

SUBMITTER: Drane CF

PROVIDER: S-EPMC6706624 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:BackgroundIn HIV infection, initiation of treatment is associated with improved clinical outcom and reduced rate of sexual transmission. However, difficulty in detecting infection in early stages impairs those benefits. We determined the minimum testing rate that maximizes benefits derived from early diagnosis.MethodsWe developed a mathematical model of HIV infection, diagnosis and treatment that allows studying both diagnosed and undiagnosed populations, as well as determining the impact of modifying time to diagnosis and testing rates. The model's external consistency was assessed by estimating time to AIDS and death in absence of treatment as well as by estimating age-dependent mortality rates during treatment, and comparing them with data previously reported from CASCADE and DHCS cohorts.ResultsIn our model, life expectancy of patients diagnosed before 8 years post infection is the same as HIV-negative population. After this time point, age at death is significantly dependent on diagnosis delay but initiation of treatment increases life expectancy to similar levels as HIV-negative population. Early mortality during HAART is dependent on treatment CD4 threshold until 6 years post infection and becomes dependent on diagnosis delay after 6 years post infection. By modifying testing rates, we estimate that an annual testing rate of 20% leads to diagnosis of 90% of infected individuals within the first 8.2 years of infection and that current testing rate in middle-high income settings stands close to 10%. In addition, many differences between low-income and middle-high incomes can be predicted by solely modifying the diagnosis delay.ConclusionsTo increase testing rate of undiagnosed HIV population by two-fold in middle-high income settings will minimize early mortality during initiation of treatment and global mortality rate as well as maximize life expectancy. Our results highlight the impact of achieving early diagnosis and the importance of strongly work on improving HIV testing rates.

Project description:BackgroundPre-exposure prophylaxis (PrEP) is highly effective in preventing HIV and has the potential to significantly impact the HIV epidemic. Given limited resources for HIV prevention, identifying PrEP provision strategies that maximize impact is critical.MethodsWe used a stochastic individual-based network model to evaluate the direct (infections prevented among PrEP users) and indirect (infections prevented among non-PrEP users as a result of PrEP) benefits of PrEP, the person-years of PrEP required to prevent one HIV infection, and the community-level impact of providing PrEP to populations defined by gender and age in western Kenya and South Africa. We examined sensitivity of results to scale-up of antiretroviral therapy (ART) and voluntary medical male circumcision (VMMC) by comparing two scenarios: maintaining current coverage ("status quo") and rapid scale-up to meet programmatic targets ("fast-track").ResultsThe community-level impact of PrEP was greatest among women aged 15-24 due to high incidence, while PrEP use among men aged 15-24 yielded the highest proportion of indirect infections prevented in the community. These indirect infections prevented continue to increase over time (western Kenya: 0.4-5.5 (status quo); 0.4-4.9 (fast-track); South Africa: 0.5-1.8 (status quo); 0.5-3.0 (fast-track)) relative to direct infections prevented among PrEP users. The number of person-years of PrEP needed to prevent one HIV infection was lower (59 western Kenya and 69 in South Africa in the status quo scenario; 201 western Kenya and 87 in South Africa in the fast-track scenario) when PrEP was provided only to women compared with only to men over time horizons of up to 5 years, as the indirect benefits of providing PrEP to men accrue in later years.ConclusionsProviding PrEP to women aged 15-24 prevents the greatest number of HIV infections per person-year of PrEP, but PrEP provision for young men also provides indirect benefits to women and to the community overall. This finding supports existing policies that prioritize PrEP use for young women, while also illuminating the community-level benefits of PrEP availability for men when resources permit.